Innovative Technology Cipherome's proprietary Xentinel platform leverages advanced bioinformatics and genomic analysis algorithms, indicating a demand for sophisticated software solutions and collaborations in personalized medicine and pharmacogenomics.

Industry Recognition Being a finalist at the AHA’s Health Technology & Innovation Competition positions Cipherome as a credible player in health tech, presenting opportunities for strategic partnerships with healthcare providers and research institutions.

Market Focus With a clear emphasis on predicting adverse drug reactions, Cipherome offers potential sales opportunities in pharmaceutical R&D, clinical genomics, and drug safety monitoring services.

Growth Potential With a revenue ranging between $1M and $10M and a small team, Cipherome is poised for rapid growth, particularly through investments and collaborations that enhance its bioinformatics capabilities.

Digital Presence Utilizing leading web technologies and cloud services like Google Workspace and Cloudflare, Cipherome is digitally well-positioned for outreach and partnership engagement, enhancing its sales and marketing efforts.